ES8400414A1 - "un procedimiento para preparar derivados de piridazinona". - Google Patents

"un procedimiento para preparar derivados de piridazinona".

Info

Publication number
ES8400414A1
ES8400414A1 ES515743A ES515743A ES8400414A1 ES 8400414 A1 ES8400414 A1 ES 8400414A1 ES 515743 A ES515743 A ES 515743A ES 515743 A ES515743 A ES 515743A ES 8400414 A1 ES8400414 A1 ES 8400414A1
Authority
ES
Spain
Prior art keywords
substituted
phenyl
pyridazinones
compounds
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515743A
Other languages
English (en)
Other versions
ES515743A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/302,181 external-priority patent/US4353905A/en
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES515743A0 publication Critical patent/ES515743A0/es
Publication of ES8400414A1 publication Critical patent/ES8400414A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE PIRIDAZINOMA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE LA LINEA DISCONTINUA REPRESENTA DOS HIDROGENOS O UN ENLACE; R2 Y R3 SON HIDROGENO O ALCOHILO INFERIOR; Y A E Y PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA REACCION DE CONDENSACION DE UN ACIDO A-OXOBENCENOBUTANOICO DE FORMULA (II) CON UNA HIDRAZINA DE FORMULA R2NHNH2, EN LAS QUE A, Y R2 Y R3 TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I); SEGUIDA DE LA EVENTUAL HIDROGENACION DEL PRODUCTO OBTENIDO. LA CONDENSACION SE LLEVA ACABO EN UN DISOLVENTE INERTE TAL COMO ETANOL A LA TEMPERATURA DE REFLUJO.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO AGENTES CARDIOTONICOS Y ANTIHIPERTENSIVOS.
ES515743A 1981-09-17 1982-09-15 "un procedimiento para preparar derivados de piridazinona". Expired ES8400414A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/302,181 US4353905A (en) 1981-09-17 1981-09-17 Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US40248882A 1982-07-27 1982-07-27
US40797382A 1982-08-13 1982-08-13

Publications (2)

Publication Number Publication Date
ES515743A0 ES515743A0 (es) 1983-10-16
ES8400414A1 true ES8400414A1 (es) 1983-10-16

Family

ID=27404868

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515743A Expired ES8400414A1 (es) 1981-09-17 1982-09-15 "un procedimiento para preparar derivados de piridazinona".

Country Status (17)

Country Link
EP (1) EP0075436B1 (es)
KR (1) KR880001623B1 (es)
AT (1) ATE18909T1 (es)
AU (1) AU563448B2 (es)
CA (1) CA1190548A (es)
DD (1) DD208615A5 (es)
DE (1) DE3270274D1 (es)
DK (1) DK414482A (es)
ES (1) ES8400414A1 (es)
FI (1) FI76084C (es)
GR (1) GR76999B (es)
HU (1) HU190412B (es)
IE (1) IE54101B1 (es)
IL (1) IL66815A (es)
NO (1) NO159595C (es)
NZ (1) NZ201929A (es)
PH (1) PH19332A (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3212304A1 (de) * 1982-04-02 1983-10-06 Nattermann A & Cie Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3241102A1 (de) * 1982-11-06 1984-05-10 A. Nattermann & Cie GmbH, 5000 Köln Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
DE3321012A1 (de) * 1983-06-10 1984-12-13 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
US4599332A (en) * 1983-12-07 1986-07-08 Warner-Lambert Company 4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)-pyridazinones and related compounds
DE3401911A1 (de) * 1984-01-20 1985-08-01 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-vinyl-3(2h)-pyridazinone und 6-vinyl-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
DE3407509A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Neue arzneimittelkombination zur behandlung von bluthochdruck und thromboembolischen erkrankungen
US4584299A (en) * 1984-05-21 1986-04-22 Warner-Lambert Company Method of treating heart failure and medicaments therefor
DE3425632A1 (de) * 1984-07-12 1986-01-16 Basf Ag, 6700 Ludwigshafen (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
IL79280A (en) * 1985-07-05 1990-07-12 Smith Kline French Lab 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
US4826835A (en) * 1985-10-23 1989-05-02 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
US4783463A (en) * 1985-10-23 1988-11-08 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
DE3600275A1 (de) * 1986-01-08 1987-07-09 Basf Ag Substituierte pyrrol-1-ylphenyldihydropyridazinone, ihre herstellung und verwendung
DE3626865A1 (de) * 1986-08-08 1988-02-11 Boehringer Mannheim Gmbh Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
DE68917485T2 (de) * 1988-01-23 1995-02-09 Kyowa Hakko Kogyo Kk Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
DE3804490A1 (de) * 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3814057A1 (de) * 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3826855A1 (de) * 1988-08-06 1990-02-15 Cassella Ag 4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
US7309701B2 (en) 2002-11-19 2007-12-18 Sanofi-Aventis Deutschland Gmbh Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
US7462613B2 (en) 2002-11-19 2008-12-09 Sanofi-Aventis Deutschland Gmbh Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1598348A1 (en) 2004-05-18 2005-11-23 Aventis Pharma Deutschland GmbH Novel pyridazinone derivatives as inhibitors of CDK2
EP1604988A1 (en) 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
TWI375669B (en) 2006-03-17 2012-11-01 Sumitomo Chemical Co Pyridazinone compound and use thereof
JP5335675B2 (ja) 2006-07-25 2013-11-06 セファロン、インク． ピリジジノン誘導体
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
EP3030252B1 (en) 2013-08-09 2018-11-07 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones
BE790106A (fr) * 1971-10-14 1973-04-13 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
ATE18909T1 (de) 1986-04-15
IE54101B1 (en) 1989-06-21
DK414482A (da) 1983-03-18
KR880001623B1 (ko) 1988-09-02
PH19332A (en) 1986-03-20
IE822250L (en) 1983-03-17
EP0075436B1 (en) 1986-04-02
FI823184L (fi) 1983-03-18
NZ201929A (en) 1985-11-08
NO159595C (no) 1989-01-18
KR840001570A (ko) 1984-05-07
ES515743A0 (es) 1983-10-16
AU8840982A (en) 1983-03-24
AU563448B2 (en) 1987-07-09
NO823128L (no) 1983-03-18
GR76999B (es) 1984-09-04
EP0075436A1 (en) 1983-03-30
FI76084C (fi) 1988-09-09
HU190412B (en) 1986-09-29
NO159595B (no) 1988-10-10
FI823184A0 (fi) 1982-09-15
DD208615A5 (de) 1984-04-04
CA1190548A (en) 1985-07-16
FI76084B (fi) 1988-05-31
DE3270274D1 (en) 1986-05-07
IL66815A0 (en) 1982-12-31
IL66815A (en) 1986-02-28

Similar Documents

Publication Publication Date Title
ES8400414A1 (es) "un procedimiento para preparar derivados de piridazinona".
YU1900A (sh) Derivati ariloksiarilsulfonilamino hidroksaminske kiseline
ES430584A1 (es) Procedimiento para la preparacion de nuevas indolil-pipe- ridino- (o 1,2,5,6-tetrahidro-piridil)-butirofenonas.
DK129282A (da) Fremgangsmaade til fremstilling af indolylethylderivater
KR860003232A (ko) 피리다지논 유도체의 제조방법
NO911158L (no) Hydantoinderivater.
MY101042A (en) Pyridazinone derivatives,process for preparation thereof, and insecticidal compotions
ES8600277A1 (es) Un procedimiento para preparar derivados de piridazinona
ES8107215A1 (es) Un procedimiento para preparar una 2-r-6-py-3(2h)-piridaci- nona
DE3572816D1 (de) Pyridazinone inotropic agents
ES8404340A1 (es) Procedimientos para preparar derivados piridazinona.
ES8606847A1 (es) Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
US3898230A (en) Sydnone imine compounds
ES8602772A1 (es) Un procedimiento de preparar un derivado de 4,5-dihidro-6-(2-(4-(1h-imidazol-1-il)-fenil)-alquilenil o alquilen-3(2h)-piridazinona.
ES466794A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES8704479A1 (es) Procedimiento para preparar piridazinonas alquil-sustituidas
US4820697A (en) 4,5-dihydro-4,4-dialkyl-6-(substituted)phenyl-3(2H)-pyridazinones useful as cardiotonic agents
SE8102660L (sv) 6-(pyridinyl)-4-substituerade-3-(2h)-pyridazinoner, anvendbara som kardiotoniska medel, och framstellning derav
US4971968A (en) Pyridazinone derivatives and salts thereof
US2792396A (en) Pyridazine carboxylic acid esters
ES8601917A1 (es) Procedimiento para producir 4,5-dihidro-6-vinil-3(2h)-piri- dazinonas y 6-vinil-3(2h)-piridazinonas
GB1511475A (en) Hydrazinopyridazine derivatives having antihypertensive activity
HUP0001545A2 (hu) Karbonsavészterszármazékok, előállításuk és alkalmazásuk herbicid hatású piridazin-3-on-származékok előállítására
US3716548A (en) 2-(chloropyridylamino)-1-pyrrolines
ES8203880A1 (es) Un procedimiento para preparar una 4,5-dihidro-2-r-4-r -6-py-3(2h)-piridazinona